Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the safety and efficacy of the 10 mg intravenous (IV) dose of tanezumab in cancer patients with pain due to bone metastases who participated in the double-blind Study A4091003 and who wish to receive open-label tanezumab therapy.
Inclusion criteria
- PAIN DUE TO BONE METASTASES